RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED THYMIDINE KINASE

PO-111.

  • Inagaki, Akihito
  • Hiraoka, Kei
  • Bogan, Brooke
  • Logg, Christopher R.
  • Kamijima, Shuichi
  • Sato, Makoto
  • Ostertag, Derek
  • Perez, Omar D.
  • Robbins, Joan M.
  • Jolly, Douglas J.
  • Gruber, Harry E.
  • Kasahara, Noriyuki

  • 1Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA

    2Tocagen Inc., San Diego, CA

The Journal of Gene Medicine 16(8):p 277, July-August 2014.
Copyright © 2014 John Wiley & Sons, Ltd